No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

1 trials linked to this intervention

Total Trials

Recruiting

With Results

Recent Trials

Combination of Cabazitaxel With Prednisolone With Primary Prophylaxis With PEG-G-CSF in Treatment of Patients With Prostate Cancer

NCT02441894Phase 4Completed21 enrolled

View all 1 trials on ClinicalTrials.gov

Research Evidence

Published studies and systematic reviews

Sort:

Comparative inhibition by oral bilastine, parenteral dexchlorpheniramine, and a new bilastine parenteral (i.v. and i.m.) formulation of histamine-induced wheal and flare response: A randomised phase I trial.

Coimbra Jimena, Puntes Montserrat, Molina Pol et al. · Eur J Pharm Sci · 2024

PMID: 39265704RCT

Repeated-dose effects of mequitazine, cetirizine and dexchlorpheniramine on driving and psychomotor performance.

Theunissen Eef L, Vermeeren Annemiek, Ramaekers Johannes G · Br J Clin Pharmacol · 2006

PMID: 16390354RCTFull text (PMC)

Gabapentin versus dexchlorpheniramine as treatment for uremic pruritus: a randomised controlled trial.

Gobo-Oliveira Mariele, Pigari Vitória G, Ogata Matheus Sp et al. · Eur J Dermatol · 2018

PMID: 29976533Observational

Ultraviolet A photosensitivity profile of dexchlorpheniramine maleate and promethazine-based creams: Anti-inflammatory, antihistaminic, and skin barrier protection properties.

Facchini Gustavo, Eberlin Samara, Clerici Stefano Piatto et al. · J Cosmet Dermatol · 2017

PMID: 28593645Observational

Development of a validated capillary electrophoresis method for enantiomeric purity testing of dexchlorpheniramine maleate.

Van Eeckhaut Ann, Detaevernier Marc Robert, Michotte Yvette · J Chromatogr A · 2002

PMID: 12134827Observational

[Anticholinergic syndrome due to dexchlorpheniramine as a cause of urinary retention].

Ortíz San Román L, Sanavia Morán E, Campos Domínguez M et al. · An Pediatr (Barc) · 2013

PMID: 23680058Case Report

Aseptic meningitis associated with intravenous administration of dexchlorpheniramine.

Lafaurie Matthieu, Dixmier Adrien, Molina Jean-Michel · Ann Med Interne (Paris) · 2003

PMID: 12910046Case Report

Simultaneous Assay of Dexchlorpheniramine Maleate, Betamethasone, and Sodium Benzoate in Syrup by a Reliable and Robust HPLC Method.

Le Dinh Chi, Ngo Thi Duyen, Hoa Le Thi Huong · J Anal Methods Chem · 2019

PMID: 31871819OtherFull text (PMC)

Determination of Acetaminophen, Dexchlorpheniramine, Caffeine, Cotinine and Salicylic acid in 100 μL of Whole Blood by UHPLC-MS/MS.

Krpo Maja, Arnestad Marianne, Karinen Ritva · J Anal Toxicol · 2018

PMID: 29186470Other

An approach to formulating an oral floating drug delivery system for dexchlorpheniramine maleate using factorial design.

Alabazi M Y, Elzein H · Pharmazie · 2012

PMID: 22888518Other

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type: Substance / Medication
Fully Specified Name: Dexchlorpheniramine (substance)
SNOMED CT: 372663001
UMLS CUI: C0057606
RxNorm CUI: 22697

Clinical Data

This intervention maps to 8 entities in the Ltrl knowledge graph.

Conditions

Biomarkers

Specialists

Symptoms

Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.